Acknowledgement
The protocol of this systematic review was registered with PROSPERO #CRD42021232591. Drs. Chah, Jones, Milord, Al-Eryani, and Enciso contributed to the conceptualization, methodology, investigation, and validation. Drs. Chah, Jones, and Milord conducted data extraction with Dr. Enciso for validation. Dr. Enciso conducted an electronic search and a formal analysis. Drs. Chah, Jones, Milord, Al-Eryani, and Enciso wrote the original draft and participated in the writing (review and editing) of the final manuscript.
References
- Vincent M, Wang S, Olesen J. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38: 1-211.
- Kaniecki RG, Levin AD. Headache in the elderly. In: Handbook of Clinical Neurology, Vol. 167 (3rd series), 1st ed. Edited by S.T. DeKosky and S. Asthana. Elsevier B.V. 2019, pp 511-28.
- Goadsby PJ. Primary headache disorders: Five new things. Neurol Clin Pract 2019; 9: 233-40. https://doi.org/10.1212/CPJ.0000000000000654
- GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018; 17: 954-76. https://doi.org/10.1016/S1474-4422(18)30322-3
- Leonardi M, Raggi A. A narrative review on the burden of migraine: when the burden is the impact on people's life. J Headache Pain 2019; 20: 41. https://doi.org/10.1186/s10194-019-0993-0
- Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001; 41: 646-57. https://doi.org/10.1046/j.1526-4610.2001.041007646.x
- Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies. Headache 2018; 58: 496-505. https://doi.org/10.1111/head.13281
- Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol 2008; 7: 354-61. https://doi.org/10.1016/S1474-4422(08)70062-0
- Cameron C, Kelly S, Hsieh SC, Murphy M, Chen L, Kotb A, et al. Triptans in the acute treatment of migraine: a systematic review and network meta-analysis. Headache 2015; 55: 221-35. https://doi.org/10.1111/head.12601
- Craven R. Ketamine. Anaesthesia 2007; 62: 48-53. https://doi.org/10.1111/j.1365-2044.2007.05298.x
- Green SM, Rotbrock SG, Lynch EL, Ho M, Harris T, Hestdalen R, et al. Intramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 cases. Ann Emerg Med 1998; 31: 688-97. https://doi.org/10.1016/S0196-0644(98)70226-4
- Sinner B, Graf BM. In: Modern Anesthetics. Handbook of Experimental Pharmacology, Volume 182. Edited by Shuttler J, Schwilden H. Berlin, Springer-Verlag. 2008, pp 313-33.
- Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, et al. Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol Rev 2018; 70: 621-60. https://doi.org/10.1124/pr.117.015198
- Mayans L, Walling A. Acute migraine headache: treatment strategies. Am Fam Physician 2018; 97: 243-51.
- Friedman BW, Hochberg ML, Esses D, Grosberg BM, Rothberg D, Bernstein B, et al. Recurrence of primary headache disorders after emergency department discharge: frequency and predictors of poor pain and functional outcomes. Ann Emerg Med 2008; 52: 696-704. https://doi.org/10.1016/j.annemergmed.2008.01.334
- Goldberg ME, Domsky R, Scaringe D, Hirsh R, Dotson J, Sharaf I, et al. Multi-day low dose ketamine infusion for the treatment of complex regional pain syndrome. Pain Physician 2005; 8: 175-9.
- Guirimand F, Dupont X, Brasseur L, Chauvin M, Bouhassira D. The effects of ketamine on the temporal summation (wind-up) of the R(III) nociceptive flexion reflex and pain in humans. Anesth Analg 2000; 90: 408-14. https://doi.org/10.1213/00000539-200002000-00031
- Lauritsen C, Mazuera S, Lipton RB, Ashina S. Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series. J Headache Pain 2016; 17: 106. https://doi.org/10.1186/s10194-016-0700-3
- The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. Edited by Higgins J, Green S. Hoboken, Wiley; 2011.
- Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 101-29. https://doi.org/10.2307/3001666
- Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58. https://doi.org/10.1002/sim.1186
- Afridi SK, Giffin NJ, Kaube H, Goadsby PJ. A randomized controlled trial of intranasal ketamine in migraine with prolonged aura. Neurology 2013; 80: 642-7. https://doi.org/10.1212/WNL.0b013e3182824e66
- Etchison AR, Bos L, Ray M, McAllister KB, Mohammed M, Park B, et al. Low-dose ketamine does not improve migraine in the emergency department: a randomized placebo-controlled trial. West J Emerg Med 2018; 19: 952-60. https://doi.org/10.5811/westjem.2018.8.37875
- Zitek T, Gates M, Pitotti C, Barlett A, Patel J, Rahbar A, et al. A comparison of headache treatment in the emergency department: prochlorperazine versus ketamine. Ann Emerg Med 2018; 71: 369-77. https://doi.org/10.1016/j.annemergmed.2017.08.063
- Benish T, Villalobos D, Love S, Casmaer M, Hunter CJ, Summers SM, et al. The THINK (treatment of headache with intranasal ketamine) trial: a randomized controlled trial comparing intranasal ketamine with intravenous metoclopramide. J Emerg Med 2019; 56: 248-57. https://doi.org/10.1016/j.jemermed.2018.12.007
- Nicolodi M, Sicuteri F. Exploration of NMDA receptors in migraine: therapeutic and theoretic implications. Int J Clin Pharmacol Res 1995; 15: 181-9.
- Pomeroy JL, Marmura MJ, Nahas SJ, Viscusi ER. Ketamine infusions for treatment refractory headache. Headache 2017; 57: 276-82. https://doi.org/10.1111/head.13013
- Niesters M, Martini C, Dahan A. Ketamine for chronic pain: risks and benefits. Br J Clin Pharmacol 2014; 77: 357-67. https://doi.org/10.1111/bcp.12094
- Messenger DW, Murray HE, Dungey PE, van Vlymen J, Sivilotti ML. Subdissociative - dose ketamine versus fentanyl for analgesia during propofol procedural sedation: a randomized clinical trial. Acad Emerg Med 2008; 15: 877-86. https://doi.org/10.1111/j.1553-2712.2008.00219.x
- Lee EN, Lee JH. The effects of low-dose ketamine on acute pain in an emergency setting: a systematic review and meta-analysis. PLoS One 2016; 11: e0165461. https://doi.org/10.1371/journal.pone.0165461
- Beaudoin FL, Lin C, Guan W, Merchant RC. Low-dose ketamine improves pain relief in patients receiving intravenous opioids for acute pain in the emergency department: results of a randomized, double-blind, clinical trial. Acad Emerg Med 2014; 21: 1193-202. https://doi.org/10.1111/acem.12510
- Carr DB, Goudas LC, Denman WT, Brookoff D, Staats PS, Brennen L, et al. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebocontrolled, crossover study. Pain 2004; 108: 17-27. https://doi.org/10.1016/j.pain.2003.07.001
- Bilhimer MH, Groth ME, Holmes AK. Ketamine for migraine in the emergency department. Adv Emerg Nurs J 2020; 42: 96-102. https://doi.org/10.1097/TME.0000000000000296
- Todd KH. A review of current and emerging approaches to pain management in the emergency department. Pain Ther 2017; 6: 193-202. https://doi.org/10.1007/s40122-017-0090-5
- Motov S, Rosenbaum S, Vilke GM, Nakajima Y. Is there a role for intravenous subdissociative-dose ketamine administered as an adjunct to opioids or as a single agent for acute pain management in the emergency department? J Emerg Med 2016; 51: 752-7. https://doi.org/10.1016/j.jemermed.2016.07.087
- Orr SL, Friedman BW, Christie S, Minen MT, Bamford C, Kelley NE, et al. Management of adults with acute migraine in the emergency department: the american headache society evidence assessment of parenteral pharmacotherapies. Headache 2016; 56: 911-40. https://doi.org/10.1111/head.12835
- Cohen SP, Bhatia A, Buvanendran A, Schwenk ES, Wasan AD, Hurley RW, et al. Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the american society of regional anesthesia and pain medicine, the american academy of pain medicine, and the american society of anesthesiologists. Reg Anesth Pain Med 2018; 43: 521-46.
- Naeem F, Schramm C, Friedman BW. Emergent management of primary headache: a review of current literature. Curr Opin Neurol 2018; 31: 286-90. https://doi.org/10.1097/WCO.0000000000000547
- Rashed A, Mazer-Amirshahi M, Pourmand A. Current approach to undifferentiated headache management in the emergency department. Curr Pain Headache Rep 2019; 23: 26. https://doi.org/10.1007/s11916-019-0765-1
- Schwenk ES, Dayan AC, Rangavajjula A, Torjman MC, Hernandez MG, Lauritsen CG, et al. Ketamine for refractory headache: a retrospective analysis. Reg Anesth Pain Med 2018; 43: 875-79.
- Turner AL, Shandley S, Miller E, Perry MS, Ryals B. Intranasal ketamine for abortive migraine therapy in pediatric patients: a single-center review. Pediatr Neurol 2020; 104: 46-53. https://doi.org/10.1016/j.pediatrneurol.2019.10.007
- Motov S, Mai M, Pushkar I, Likourezos A, Drapkin J, Yasavolian M, et al. A prospective randomized, double-dummy trial comparing IV push low dose ketamine to short infusion of low dose ketamine for treatment of pain in the ED. Am J Emerg Med 2017; 35: 1095-100. https://doi.org/10.1016/j.ajem.2017.03.004
- Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, et al. The International Classification of Headache Disorders. 2nd edition. ICHD-2. Cephalalgia 2004; 24: 1-160.
- Olesen J, Bendtsen L, Dodick D, Ducros A, Evers S, First M, et al. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629-808. https://doi.org/10.1177/0333102413485658
- Olesen J, Bes A, Kunkel R, Lance JW, Nappi G, Pfaffenrath V, et al. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988; 8 Suppl 7: 1-96. https://doi.org/10.1046/j.1468-2982.1988.0801001.x